cTnI:Mainly used as an aid in the diagnosis of myocardial infarction;
D-Dimer:Mainly used as an aid in the diagnosis of disseminated intravascular coagulation;
NT-proBNP:Primarily used as an aid in the diagnosis of heart failure.
Applicable to various sample types of plasma and whole blood
Rapid detection of single reagent (15 minutes)
Convenient storage and transportation at room temperature
Successfully obtained in the EU CE access certification.
Clinical significance:
The combined test can effectively help clinicians to quickly determine or rule out diseases that cause acute chest pain with dyspnea, and provide early risk stratification and determination of patients, thus helping doctors to diagnose the condition.
Main clinical applications:
1.Rapid identification of high-risk chest pain and differentiation of dyspnea of cardiac and pulmonary origin;
2.Differential diagnosis of aortic coarctation disease and risk stratification of patients.
Applicable departments:
Cardiology, Cardiac Surgery, Emergency, ICU.
Sample type:plasma and whole blood
Report time:15min
Reference range:cTnI≤0.3 ng/mL;D-Dimer<0.5 mg/L;NT-proBNP(under 75 :<300 pg/mL; 75 and over:<450 pg/mL)
Storage:4-30℃,sealed and kept away from light and dry
Validity period:18months
Specifications:25 tests/box,50 tests/box